NCT03479697View on ClinicalTrials.gov

HIRREM for Stage 1 Primary Hypertension

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions
HypertensionBlood PressureCardiovascular DiseasesCardiovascular Risk FactorAutonomic Nervous System Imbalance
Interventions
DEVICE

HIRREM

Technology

OTHER

Continued Current Care

Continue their current clinical care.

Trial Locations (1)

27157

Department of Neurology, Wake Forest School of Medicine, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03479697 - HIRREM for Stage 1 Primary Hypertension | Biotech Hunter | Biotech Hunter